Cubist Systematic Strategies’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $25.3K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $36.5K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $277K | Sell |
|
|||||
|
2022
Q4 | $698K | Buy |
|
|||||
|
2022
Q3 | $981K | Sell |
|
|||||
|
2022
Q2 | $2.33M | Buy |
|
|||||
|
2022
Q1 | $1.24M | Buy |
|
|||||
|
2021
Q4 | $1.07M | Buy |
|
|||||
|
2021
Q3 | $826K | Buy |
|
|||||
|
2021
Q2 | $411K | Buy |
|
|||||
|
2021
Q1 | $371K | Buy |
|
|||||
|
2020
Q4 | $58K | Sell |
|
|||||
|
2020
Q3 | $139K | Sell |
|
|||||
|
2020
Q2 | $341K | Buy |
|
|||||
|
2020
Q1 | $12K | Buy |
|